Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events

Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events

Background Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of a...

Полное описание

Библиографические подробности
Главные авторы:	Laura D’Erasmo, Ilenia Minicocci, Alessia Di Costanzo, Giovanni Pigna, Daniela Commodari, Fabrizio Ceci, Anna Montali, Francesca Brancato, Ilaria Stanca, Antonio Nicolucci, Andrea Ascione, Nicola Galea, Iacopo Carbone, Marco Francone, Marianna Maranghi, Marcello Arca
Формат:	Статья
Язык:	English
Опубликовано:	Wiley 2021-05-01
Серии:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Предметы:	atherosclerosis cardiovascular disease genetics hypercholesterolemia therapy
Online-ссылка:	https://www.ahajournals.org/doi/10.1161/JAHA.120.018932

Схожие документы

Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
по: Agnieszka Mickiewicz, и др.
Опубликовано: (2020-05-01)

Family and polygenic hypercholesterolemia: similarities and differencies by long-term follow-up
по: B M Lipovetskiy, и др.
Опубликовано: (2009-03-01)

A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin
по: Luis G. Leal, и др.
Опубликовано: (2020-06-01)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
по: Isabella Ramos Lima, и др.
Опубликовано: (2022-08-01)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
по: Timothy Lee, BSc, и др.
Опубликовано: (2019-05-01)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
по: Estíbaliz Jarauta, и др.
Опубликовано: (2020-12-01)

Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries
по: Marcello Arca, и др.
Опубликовано: (2023-11-01)

Clinical Significance of Screening for Familial Hypercholesterolemia in Patients with Hypercholesterolemia
по: LI Yuan, MA Hongyang, LI Biao, YUE Anna, SHAO Yaqing, SUN Kangyun
Опубликовано: (2024-12-01)

LIPOPROTEIN (a) LEVELS IN MONOGENIC VERSUS POLYGENIC HYPERCHOLESTEROLEMIA
по: A. Jain, и др.
Опубликовано: (2021-09-01)

Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
по: Elena Olmastroni, и др.
Опубликовано: (2022-04-01)

New Treatments on the Horizon for Familial Hypercholesterolemia
по: Khalid Al-Rasadi, и др.
Опубликовано: (2017-11-01)

Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
по: Marco Ambrosetti, и др.
Опубликовано: (2015-08-01)

The panorama of familial hypercholesterolemia in Latin America: a systematic review[S]
по: Roopa Mehta, и др.
Опубликовано: (2016-12-01)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
по: Seyedmohammad Saadatagah, и др.
Опубликовано: (2022-12-01)

Genetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and “Missing” Heritability
по: Jesús Maria Martín-Campos
Опубликовано: (2021-11-01)

SITOSTEROLEMIA – RARE CAUSE OF HYPERCHOLESTEROLEMIA IN CHILD
по: Antoneta Dacia Petroaie
Опубликовано: (2019-02-01)

Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity
по: Amal Chamli, и др.
Опубликовано: (2023-03-01)

Role of lipoprotein apheresis in the management of familial hypercholesterolemia
по: Shamanna Seshadri Iyengar, и др.
Опубликовано: (2021-01-01)

School-based universal screening for hypercholesterolemia in children
по: Chang-Hsien Yu, и др.
Опубликовано: (2022-07-01)

The prevalence of familial hypercholesterolemia in teenagers from Timișoara
по: Andreea Dumitrescu¹,²,, и др.
Опубликовано: (2016-12-01)

Effects of <i>Lippia citriodora</i> Leaf Extract on Lipid and Oxidative Blood Profile of Volunteers with Hypercholesterolemia: A Preliminary Study
по: Antonella Angiolillo, и др.
Опубликовано: (2021-03-01)

Familial hypercholesterolemia revealed by multiple xanthomas
по: Nassiba Elouarradi, и др.
Опубликовано: (2018-05-01)

A case of familial hypercholesterolemia
по: Augusto Zaninelli
Опубликовано: (2008-06-01)

Monacolin K in the treatment of hypercholesterolemia - chance or threat?
по: Katarzyna Krotowska
Опубликовано: (2024-12-01)

Immune Modulatory Effects of Hypercholesterolemia: Can Atorvastatin Convert the Detrimental Effect of Hypercholesterolemia on the Immune System?
по: Zeinab Emruzi, и др.
Опубликовано: (2019-10-01)

Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
по: Z. D. Kobalava, и др.
Опубликовано: (2020-11-01)

Relationship between hypercholesterolemia and osteoarthritis (preliminary results)
по: Elena A. Taskina, и др.
Опубликовано: (2024-06-01)

Early Atherosclerosis in Children in Familial Hypercholesterolemia : A 2 Case Report
по: Narumon Densupsoontorn, и др.
Опубликовано: (2020-08-01)

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
по: Chamberlin KW, и др.
Опубликовано: (2015-04-01)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
по: Elena Olmastroni, и др.
Опубликовано: (2023-05-01)

Safety and Effectiveness of Low‐Density Lipoprotein Cholesterol–Lowering Therapy With Evolocumab for Familial Hypercholesterolemia/Hypercholesterolemia in Japan: A Real‐World, Postmarketing, Single‐Arm Study
по: Koutaro Yokote, и др.
Опубликовано: (2024-11-01)

Amaranthus viridis L. as alternative treatment for hypercholesterolemia and atherosclerosis
по: Salvamani, Shamala
Опубликовано: (2016)

Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
по: Natalya G. Lozhkina, и др.
Опубликовано: (2022-01-01)

Doppler study of cerebral arteries in hypercholesterolemia
по: Ghabili K
Опубликовано: (2011-03-01)

Genetic Testing for Familial Hypercholesterolemia in a Pediatric Group: A Romanian Showcase
по: Andreea Teodora Constantin, и др.
Опубликовано: (2023-06-01)

Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype
по: Ana Margarida Medeiros, и др.
Опубликовано: (2024-02-01)

Familial hypercholesterolemia: The skin speaks
по: Johns T Johnson, и др.
Опубликовано: (2020-01-01)

The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects
по: Ilhame Diboun, и др.
Опубликовано: (2022-07-01)

Patient experiences align with the familial hypercholesterolemia global call to action
по: Laney K. Jones, и др.
Опубликовано: (2022-06-01)

Scientific Disagreement and Evidential Pluralism: Lessons from the Studies on Hypercholesterolemia
по: Veli-Pekka Parkkinen, и др.
Опубликовано: (2018-05-01)